Addressing the limitations of the regulatory landscape in South Africa regarding advanced cell and gene therapies and related sectors involving human cells, tissues and organs
Advanced cell-based and gene therapy products emerged during the 1990s as new health product categories for treating and curing previously untreatable or incurable conditions. These products are complex, diverse and therapeutically specific, requiring specialised regulatory frameworks. During t...
Saved in:
Main Authors: | I M Viljoen, M S Pepper |
---|---|
Format: | Article |
Language: | English |
Published: |
South African Medical Association
2025-02-01
|
Series: | South African Medical Journal |
Subjects: | |
Online Access: | https://samajournals.co.za/index.php/samj/article/view/2629 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Public Administration’s Regulatory Acts: Classification Issues
by: V. R. Bila
Published: (2019-12-01) -
The efficiency of the interim relief institution by suspending an individual or regulatory act
by: M. V. Kluban, et al.
Published: (2023-07-01) -
Safe Harbor Agreement: A Regulatory Assurance under the Endangered Species Act
by: Melissa M. Kreye, et al.
Published: (2016-02-01) -
Safe Harbor Agreement: A Regulatory Assurance under the Endangered Species Act
by: Melissa M. Kreye, et al.
Published: (2016-02-01) -
The Devil's Disciple
by: Shaw, George Bernad
Published: (2008)